Covetrus 70 Million Settlement Over Alleged Unfair 21 Per Share Buyout and Fiduciary Breaches

This class action arises from Covetrus Inc.’s Oct. 13, 2022, $21-per-share cash buyout by affiliates of private equity firms (led by Clayton, Dubilier & Rice LLC and TPG), and it alleges that CD&R leveraged its position as a major stockholder and board member to force an unfair sale price and that defendants issued a materially misleading proxy. Plaintiffs sought damages for breaches of fiduciary duty and aiding and abetting those breaches; the parties agreed to a $70 million settlement (to be divided pro rata among eligible record and beneficial holders who exchanged shares for $21, after administration costs, taxes, and up to $14.7 million in fees and up to $20,000 in service awards). The class is certified solely for settlement under Delaware Chancery Court rules (a non‑opt‑out class), the claims were denied by defendants who settled to avoid litigation, and a fairness hearing is scheduled for April 13, 2026. Beyond the immediate payout, the case highlights recurring tensions when private equity sponsors that are also significant shareholders pursue take‑private deals: Delaware fiduciary law requires boards and controlling stockholders to secure fair value and full disclosure, and the SEC’s proxy rules demand accurate material information for voting stockholders. Similar suits frequently target potential conflicts of interest in sponsor-led buyouts and often end in settlements rather than definitive rulings, which can push acquirers and boards to strengthen sale processes and disclosures to reduce litigation risk and protect minority investors.